Main competitors
Consensus (Composite) Analysts' target price evolution (4 months) Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Average Target P. Ecart obj. / dr Nbr of analysts
US$57.89 +38.55% 26
CHF 658.11 +17.94% 22
₩215,152.97 +20.33% 22
US$330.95 +37.33% 23
US$189.65 +16.75% 19
€59.73 -0.91% 14
US$175.2 +18.71% 15
US$195.94 +30.64% 16
US$50.35 +5.94% 15
US$66.7 +14.98% 10
US$300.2 -5.87% 12
US$130.6 +1.71% 15
US$67.28 +30.55% 13
US$156.14 +1.46% 17
US$72.91 +98.82% 11
CN¥53.6 +1.16% 13
CN¥29.91 +24.94% 11
CHF 71 +24.56% 8
Average 12,101.06 +20.98% 16
Weighted average by Cap. 24,699.29 +20.41% 18
Other Biotechnology & Medical Research